Analysis – Goldea Capital

Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome

Written by Customer Service on December 14, 2025. Posted in Public Companies.

– Company to host live webcast and conference call Monday, December 15, 2025 at 8:00 am ET – EMERYVILLE, Calif., Dec. 14, 2025 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced it will host a live webcast and conference call on Monday, December 15, 2025 at 8:00 am ET to review topline results from the registrational Phase 2 KYSA-8 clinical trial evaluating KYV-101 in stiff person syndrome (SPS). Conference Call Details Participants will need to register at the below-noted URL in order to listen and participate in the call. Once registered, participants will receive a dial-in phone number and unique PIN number which will be needed to join the call. The call can also be accessed via live webcast....

EDF: Update on the Flamanville EPR: the reactor has reached 100% of nuclear thermal power

Written by Customer Service on December 14, 2025. Posted in Public Companies.

Update on the Flamanville EPR: the reactor has reached 100% of nuclear thermal power 14 December 2025 marks a major milestone : the Flamanville 3 reactor reached 100% nuclear thermal power at 11:37am and generated 1,669MW of gross electrical power*. The ramp-up to 100% nuclear thermal power follows the approval by the French nuclear safety and radiation protection authority (ASNR) on 12 December 2025, to go beyond the 80% threshold. Reaching the 100% mark for the first time enables testing of equipment at full power, taking of measurements and verifying that everything is functioning properly. Over the coming weeks, and as part of the start-up program, the power of the reactor will vary to continue testing at different power levels and an operation will be carried out on an internal electrical substation. This milestone reflects the...

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

Written by Customer Service on December 14, 2025. Posted in Public Companies.

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the phase IIb clinical study of novel BTK inhibitor orelabrutinib has met the primary endpoint in patients with systemic lupus erythematosus (SLE). InnoCare has also received approval from the Center for Drug Evaluation (CDE) to conduct a phase III registrational clinical trial. Orelabrutinib demonstrated outstanding efficacy and well-tolerated safety profile in patients with SLE who had received 48 weeks of treatment in the phase IIb study. A total of 187 patients were enrolled and randomized (1:1:1) into three groups: orelabrutinib 75 mg once-daily (QD), orelabrutinib 50 mg QD, and placebo. The primary endpoint of this study...

Pollock Company Acquires ATG Communications, Strengthening Local Technology Infrastructure

Written by Customer Service on December 14, 2025. Posted in Mergers And Acquisitions.

Acquisition Expands High-Speed Internet, Voice, and Technology Services for Local BusinessesPollock Company Logo AUGUSTA, Ga., Dec. 14, 2025 (GLOBE NEWSWIRE) — Pollock Company, a third-generation, family-owned leader in office technology, managed IT services, and physical security solutions for more than 60 years, proudly announces the acquisition of ATG Communications, a respected local Internet and Voice Service Provider serving the community for 36 years. This strategic acquisition represents a major investment in the local community and a key step forward in Pollock Company’s mission to deliver comprehensive, end-to-end technology solutions. By integrating ATG Communications’ reliable internet and voice infrastructure with Pollock Company’s broad portfolio — including managed IT, cybersecurity, print solutions, workflow optimization,...

Mission Success: Rocket Lab Deploys First Dedicated Launch for Japan Aerospace Exploration Agency (JAXA)

Written by Customer Service on December 14, 2025. Posted in Public Companies.

MAHIA, New Zealand, Dec. 13, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its first dedicated mission for the Japan Aerospace Exploration Agency (JAXA) – a pivotal marker of Electron’s global importance for regular, reliable, and dedicated access to space. The “RAISE And Shine” mission lifted off from Rocket Lab Launch Complex 1 in New Zealand on December 14, 2025 at 03:09 UTC / 16:09 NZDT to successfully deploy the agency’s RApid Innovative payload demonstration SatellitE-4 (RAISE-4) spacecraft: a demonstration of eight technologies developed by private companies, universities, and research institutions throughout Japan. The mission was the first of two dedicated missions for JAXA’s Innovative Satellite...

Exor Press Release – Announcement on Juventus

Written by Customer Service on December 13, 2025. Posted in Mergers And Acquisitions.

Amsterdam, 13 December 2025 EXOR BOARD UNANIMOUSLY REJECTS TETHER’S PROPOSAL TO ACQUIRE EXOR’S CONTROLLING STAKE IN JUVENTUS Exor N.V. (“Exor” or the “Company”) announces that its Board of Directors has unanimously rejected an unsolicited proposal submitted by Tether Investments, S.A. de C.V. (“Tether”) to acquire all of the shares of Juventus Football Club S.p.A. (“Juventus” or the “Club”) owned by Exor. Exor reaffirms its previous, consistent statements that it has no intention of selling any of its shares in Juventus to a third party, including but not restricted to El Salvador-based Tether. Juventus is a storied and successful club, of which Exor and the Agnelli family are the stable and proud shareholders for over a century, and they remain fully committed to the Club, supporting its new management team in the execution of a clear...

Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery

Written by Customer Service on December 13, 2025. Posted in Public Companies.

QUEBEC CITY, Dec. 13, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Corporation”) (TSX-V: RBX, ASX: RXR) announces that, further to the announcement on December 10, 2025, it has filed an addendum (the “Addendum”) to the management information circular of the Corporation dated November 11, 2025 (the “Circular”). The Addendum provides certain information regarding the amending agreement (the “Amending Agreement”) entered into between Robex, Predictive Discovery Limited (“Predictive”) (ASX: PDI) and 9548-5991 Québec Inc. (“Acquireco”) to amend the previously announced arrangement agreement dated October 5, 2025 among Robex, Predictive and Acquireco (together with the Amending Agreement, the “Arrangement Agreement”), pursuant to which Acquireco, a direct wholly-owned subsidiary of Predictive, will acquire all of the...

Cornish Metals Obtains Final Order for Plan of Arrangement

Written by Customer Service on December 13, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSXV: CUSN) (“Cornish Metals”, “Cornish Canada” or the “Company”), a mineral exploration and development company focused on advancing its wholly owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to announce that the Company has obtained a final order from the Ontario Superior Court of Justice approving the previously announced re-domicile of the Company to the United Kingdom by way of a statutory plan of arrangement (the “Arrangement”). As previously disclosed by the Company, the Arrangement will result in the transfer all of the issued and outstanding common shares of the Company (each a “Cornish Canada Share”) to Cornish Metals plc (“Cornish UK”) in exchange for the issue to the Company’s shareholders of...

Fobi AI Announces Partial Revocation Order and Non-Brokered Private Placement

Written by Customer Service on December 13, 2025. Posted in Public Companies.

Not for distribution to U.S. news wire services or dissemination in the United States VANCOUVER, BC, Dec. 12, 2025 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV) (FOBIF: Pink) (the “Company” or “Fobi”), is pleased to announce that the British Columbia Securities Commission has granted a partial revocation order dated December 12, 2025 (the “Partial Revocation Order”) to the failure-to-file cease trade order issued in respect of the Company on November 1, 2024 (the “CTO”) to permit the Company to complete a non-brokered private placement financing (the “Offering”) of up to 30,000,000 units of the Company (“Units”) at a price per Unit of C$0.05 (the “Offering Price”) for aggregate gross proceeds of up to C$1,500,000. Each Unit shall consist of one (1) Common Share of the Company (each a “Share”) and one (1) Share...

Rio Silver Closes the Acquisition of the Maria Norte Ag-Au-Pb-Zn Property in Central Peru

Written by Customer Service on December 13, 2025. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (the “Company” or “Rio Silver”) (TSX.V: RYO) (OTC: RYOOF) announces that, following regulatory approval, the closing of the previously-announced transaction (the “Transaction”) with Peruvian Metals Corp. (“Peruvian”) to acquire 100% of the issued and outstanding common shares of Mamaniña Exploraciones S.A.C. (the “Subsidiary”), a Peruvian corporation, which holds mining rights in the Maria Norte project (the “Maria Norte Property”) located in Peru. The details and the terms of the Transaction are summarized in the Company’s previous press releases on March 26, June 25 and September 17, 2025. Pursuant to the terms of the Transaction, on closing, Rio Silver has acquired from Peruvian 100% of the issued and outstanding common shares of the Subsidiary. In...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals